Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada

Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada Bharat Biotech on June 3 said it has agreed to expand the agreement with Ocugen Inc to commercialise the jab in Canada also. https://ift.tt/eA8V8J

No comments:

Post a Comment